The primary goal of Deaminet 2021 is to bring together investigators interested in base editing enzymes, predominantly APOBEC and ADAR deaminase family members but also other promising enzymes, and discuss ways to harness their activities toward editing for beneficial purposes. Topics will range from fundamental biology to translational and applied applications and include studies on all kingdoms of life. Speakers and participants will represent both academic and commercial interests. An additional goal will be providing an exceptionally comfortable and stimulating atmosphere for the cultivation of new and cross-disciplinary collaborations and ideas and discussions of the rapidly expanding editing field.
The CRISPR Journal is the only peer-reviewed publication dedicated to the science and applications of gene editing. Spearheaded by Editor-in-Chief Rodolphe Barrangou, PhD and aided by a diverse and accomplished editorial board, the Journal provides a high-profile forum for cutting-edge international original research papers, as well as a compelling mixture of frontmatter content— review articles, perspectives, profiles, and commentary spanning not only matters of research but the many social, ethical, and business issues confronting the field. The CRISPR Journal centralizes essential information and analysis on this revolutionary technology in a single location with the aim of solidifying and growing the community of innovative researchers, practitioners, policymakers, and activists who make up the field of gene editing.
Check out this virtual event at Deaminet 2021